Association of Lp-PLA2 activity and LDL size with interleukin-6, an inflammatory cytokine and oxidized LDL, a marker of oxidative stress, in women with metabolic syndrome

被引:25
作者
Chae, Jey Sook [2 ]
Kim, Oh Yoen [2 ]
Paik, Jean Kyung [2 ]
Kang, Ryungwoo [2 ,3 ]
Seo, Woo Ju [2 ]
Jeong, Tae-Sook [4 ]
Sweeney, Gary [5 ,6 ]
Lee, Sang-Hyun [7 ]
Lee, Jong Ho [1 ,2 ,3 ]
机构
[1] Yonsei Univ, Dept Food & Nutr, Coll Human Ecol, Natl Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea
[2] Yonsei Univ, Res Inst Sci Aging, Seoul 120749, South Korea
[3] Yonsei Univ, Coll Human, Brain Korea 21 Project, Dept Food & Nutr, Seoul 120749, South Korea
[4] Korea Res Inst Biosci & Biotechnol, Natl Res Lab Lipid Metab & Atherosclerosis, Taejon, South Korea
[5] Inst Pasteur Korea, Seoul, South Korea
[6] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada
[7] Natl Hlth Insurance Corp Ilsan Hosp, Dept Family Practice, Goyang Si, South Korea
基金
新加坡国家研究基金会;
关键词
Lp-PLA(2) activity; Interleukin-6; Oxidized LDL; LDL size; Metabolic syndrome; Women; ACTIVATING-FACTOR-ACETYLHYDROLASE; PHOSPHOLIPASE A(2) ACTIVITY; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; RISK; ATHEROSCLEROSIS; EPIDEMIOLOGY;
D O I
10.1016/j.atherosclerosis.2011.06.036
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We investigated an association between lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity, inflammation, and oxidative stress in women with metabolic syndrome (MS). Methods: We performed a case-control study in MS women (n = 368) and non-MS women (n = 854). Lp-PLA(2) activity LDL particle size; leukocyte number; ox-LDL, LDL-cholesterol, TNF-alpha, IL-6, and CRP levels were measured. Results: MS women had smaller LDL particle size; higher plasma ox-LDL levels and Lp-PLA(2) activity; and higher serum TNF-alpha, IL-6, and CRP, than non-MS women. In controls, Lp-PLA(2) activity weakly but significantly correlated with LDL-cholesterol; in MS women, Lp-PLA(2) activity positively correlated with LDL-cholesterol, ox-LDL, TNF-alpha, and IL-6 after adjusting for age and BMI. The relationship between Lp-PLA(2) activity and ox-LDL still maintained after further adjustment for LDL-cholesterol. Additionally, Lp-PLA(2) activity together with LDL particle size were significant independent predictors of MS (multivariate analysis), and ox-LDL was a major contributor to the increase in Lp-PLA(2) activity in MS women (multiple stepwise regression). In a subgroup analysis, Lp-PLA(2) activity was negatively associated with IL-6 levels in non-MS postmenopausal women, but positively with IL-6 in both postmenopausal and premenopausal women with MS. Postmenopausal women with MS had significantly higher Lp-PLA(2) activity, ox-LDL and IL-6 than those without MS, and premenopausal women with or without MS, after the adjustment. Conclusions: Elevated plasma Lp-PLA(2) activity was associated with an increase in inflammatory cytokines, particularly IL-6 and ox-LDL in MS women. This association was also affected by menopause status, suggesting that Lp-PLA(2) may represent a novel marker for oxidation and inflammation in MS. Crown Copyright (C) 2011 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:499 / 506
页数:8
相关论文
共 29 条
[1]   Gender Differences Relating to Metabolic Syndrome and Proinflammation in Finnish Subjects with Elevated Blood Pressure [J].
Ahonen, Tiina ;
Saltevo, Juha ;
Laakso, Markku ;
Kautiainen, Hannu ;
Kumpusalo, Esko ;
Vanhala, Mauno .
MEDIATORS OF INFLAMMATION, 2009, 2009
[2]   Association of Carotid Plaque Lp-PLA2 with Macrophages and Chlamydia pneumoniae Infection among Patients at Risk for Stroke [J].
Atik, Berna ;
Johnston, S. Claiborne ;
Dean, Deborah .
PLOS ONE, 2010, 5 (06)
[3]   Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [J].
Ballantyne, CM ;
Hoogeveen, RC ;
Bang, H ;
Coresh, J ;
Folsom, AR ;
Heiss, G ;
Sharrett, AR .
CIRCULATION, 2004, 109 (07) :837-842
[4]   Lipoprotein-associated phospholipase A2:: a new biomarker for cardiovascular risk assessment and potential therapeutic target [J].
Carlquist, John F. ;
Muhlestein, Joseph B. ;
Anderson, Jeffrey L. .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (05) :511-517
[5]   Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs [J].
De Keyzer, Dieuwke ;
Karabina, Sonia-Athina ;
Wei, Wenhzong ;
Geeraert, Benjamine ;
Stengel, Dominique ;
Marsillach, Judit ;
Camps, Jordi ;
Holvoet, Paul ;
Ninio, Ewa .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (12) :2041-U132
[6]   Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus [J].
Derbent, Aysel ;
Kargili, Ayse ;
Koca, Cemile ;
Guemues, Ilknur Inegoel ;
Sevgili, Sema ;
Simavli, Serap ;
Karakurt, Feridun ;
Turhan, Nilguen Oeztuerk .
GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (02) :128-133
[7]   Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults [J].
Detopoulou, Paraskevi ;
Nomikos, Tzortzis ;
Fragopoulou, Elizabeth ;
Panagiotakos, Demosthenis B. ;
Pitsavos, Christos ;
Stefanadis, Christodoulos ;
Antonopoulou, Smaragdi .
LIPIDS IN HEALTH AND DISEASE, 2009, 8
[8]   Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort:: The Cardiovascular Health Study [J].
Furberg, Curt D. ;
Nelson, Jeanenne J. ;
Solomon, Cam ;
Cushman, Mary ;
Jenny, Nancy Swords ;
Psaty, Bruce M. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (05) :792-799
[9]   Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma [J].
Gazi, I ;
Lourida, ES ;
Filippatos, T ;
Tsimihodimos, V ;
Elisaf, M ;
Tselepis, AD .
CLINICAL CHEMISTRY, 2005, 51 (12) :2264-2273
[10]   Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria [J].
Gazi, Irene ;
Tsimihodimos, Vasilis ;
Filippatos, Theodosios ;
Bairaktari, Eleni ;
Tselepis, Alexandros D. ;
Elisaf, Moses .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (07) :885-891